Cytosorbents (CTSO) Tops Q2 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $9.68 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Genco Shipping urges shareholders to reject Diana's $24.80 takeover bid
• CrowdStrike Holdings Inc. (CRWD) Tops Q1 EPS by 3c, Offers Guidance